1219019-23-4 Usage
Description
(6S)-6,7-dihydro-5H-Pyrrolo[1,2-a]imidazol-6-ol is an organic compound with a unique chemical structure, characterized by its imidazol ring fused with a pyrrolo ring. It is a chiral molecule with a specific (6S) configuration, which plays a crucial role in its reactivity and potential applications.
Uses
Used in Pharmaceutical Industry:
(6S)-6,7-dihydro-5H-Pyrrolo[1,2-a]imidazol-6-ol is used as an intermediate for the synthesis of (6R)-6,7-Dihydro-5H-pyrrolo[1,2-a]imidazol-6-amine (D449985), a compound with potential pharmaceutical applications. Its role as a building block allows for the development of more complex pharmaceutical compounds, which can be tailored for specific therapeutic purposes.
Used in Chemical Synthesis:
(6S)-6,7-dihydro-5H-Pyrrolo[1,2-a]imidazol-6-ol is also used as a building block in the chemical synthesis of various organic compounds. Its unique structure and reactivity make it a valuable component in the creation of novel molecules with potential applications in different industries, such as materials science, agrochemicals, and more.
Check Digit Verification of cas no
The CAS Registry Mumber 1219019-23-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,1,9,0,1 and 9 respectively; the second part has 2 digits, 2 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1219019-23:
(9*1)+(8*2)+(7*1)+(6*9)+(5*0)+(4*1)+(3*9)+(2*2)+(1*3)=124
124 % 10 = 4
So 1219019-23-4 is a valid CAS Registry Number.
1219019-23-4Relevant articles and documents
AMIDE COMPOUNDS USEFUL IN THERAPY
-
Page/Page column 158, (2010/04/25)
A compound of Formula (I), or a pharmaceutically acceptable salt or solvate thereof, (I) wherein, R1 and R2 each independently represent H, halogen, CF3, C1-3 alkyl or C1-3 alkoxy; R3 represents C1-6 alkyl, C3-6 cycloalkyl, phenyl (optionally substituted by one or more substituents each independently selected from Ra) or Het (optionally substituted by one or more substituents each independently selected from OH, oxo, or C1-4 alkyl); R4 represents H or C1-3 alkyl; R5 represents C1-6 alkyl (optionally substituted by one or more substituents each independently selected from Rb), C3-6 cycloalkyl (optionally substituted by one or more substituents each independently selected from oxo or OH), or Het2 (optionally substituted by one or more substituents each independently selected from Rd); oxygen atom or 1 sulphur atom, or (c) 1 oxygen atom or 1 sulphur atom, (optionally substituted by one or more substituents each independently selected from OH, oxo or C1-4 alkyl); and R6 represents C1-3 alkyl (optionally substituted by one or more substituents each independently selected from Rf), C3-5 cycloalkyl (optionally substituted by one or more halogen), CN or halogen; where Rf represents halogen or phenyl: and compositions, processes for the preparation, and uses thereof, e.g. in the treatment of endometriosis or uterine fibroids.
